Storage and handling
Store tightly closed container in a dry place at temperatures not exceeding 35°C (95°F).
Store tightly closed container in a dry place at temperatures not exceeding 35°C (95°F).
PanaKare Plus Tablets
Pancreatic Enzyme Concentrate
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FOR ANIMAL USE ONLY
Each tablet contains a minimum of:
Lipase..............................9,000 USP units
Protease.........................57,000 USP units
Amylase..........................64,000 USP units
PanaKare Plus is a pancreatic enzyme concentrate of porcine origin.
Discontinue use in animals with symptoms of sensitivity or allergy.
Made in the USA of U.S. and imported materials
KEEP OUT OF REACH OF CHILDREN
Indications:
As a digestive aid in replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.
Directions for use:
Dose is administered before each meal. Estimate dose according to the severity of the condition and weight of the animal.
Average dose/meal:
Dogs: 2-3 tablets
Cats: 1/2-1 tablet
Store tightly closed container in a dry place at temperatures not exceeding 35°C (95°F).
Manufactured by: Neogen Corporation
Lexington, KY 40511 859-254-1221
neogen.com
NDC: 59051-9067-7
PanaKare Plus Tablets
Pancreatic Enzyme Concentrate
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Net Contents: 500 Tablets
NDC: 59051-9067-5
PanaKare Plus Tablets
Pancreatic Enzyme Concentrate
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Net Contents: 100 Tablets
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1421001 | lipase 9,000 UNT / amylase 64,000 UNT / protease 57,000 UNT Oral Tablet | PSN | 10 |
| 1421007 | PanaKare Plus 9000 UNT / 64,000 UNT / 57,000 UNT Oral Tablet | PSN | 10 |
| 1421007 | amylase 64000 UNT / lipase 9000 UNT / protease 57000 UNT Oral Tablet [PanaKare] | SBD | 10 |
| 1421001 | amylase 64000 UNT / lipase 9000 UNT / protease 57000 UNT Oral Tablet | SCD | 10 |
| 1421001 | amylase 64,000 UNT / protease 57,000 UNT / lipase 9,000 UNT Oral Tablet | SY | 10 |
| 1421001 | amylases 64,000 UNT / endopeptidases 57,000 UNT / lipase 9000 UNT Oral Tablet | SY | 10 |
| 1421007 | PanaKare (amylase 64,000 UNT / protease 57,000 UNT / lipase 9,000 UNT) Oral Tablet | SY | 10 |
| 1421007 | PanaKare (amylases 64,000 UNT / endopeptidases 57,000 UNT / lipase 9000 UNT) Oral Tablet | SY | 10 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0b1603b8-969e-b082-f6f5-ad66d8a6ea8a | Product name | 2 | 20200325 |
| 19041f15-771b-3d3a-88fc-f5e2d079cd6d | Product name | 2 | 20200325 |
| 1987d950-08e4-4b70-adeb-fb67a71142ab | Product name | 2 | 20200325 |
| 8825ddf7-1520-4680-b0ee-684e2fa73672 | Product name | 2 | 20200325 |
| 267a6f34-90b4-2f48-3063-4f505d06a7be | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59051-9067-5 | PanaKare Plus | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 10 | |
| 59051-9067-7 | PanaKare Plus | 500 in 1 BOTTLE, PLASTIC | TABLET | 500 | 10 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59051-9067 | PANAKARE PLUS (PANCREATIC ENZYME) TABLET [NEOGEN CORPORATION-MERCER] | 10 | 2 package rows | 20240124_c9b7ae4f-3463-4054-9ad8-b75b0bd3b20f.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PANCRELIPASE AMYLASE | ACTIVE INGREDIENT | YOJ58O116E | 3 | |
| PANCRELIPASE LIPASE | ACTIVE INGREDIENT | 8MYC33932O | 3 | |
| PANCRELIPASE PROTEASE | ACTIVE INGREDIENT | 3560D81V50 | 3 | |
| PANCRELIPASE AMYLASE | ACTIVE MOIETY | YOJ58O116E | 3 | |
| PANCRELIPASE LIPASE | ACTIVE MOIETY | 8MYC33932O | 3 | |
| PANCRELIPASE PROTEASE | ACTIVE MOIETY | 3560D81V50 | 3 | |
| ALPHA-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | 3 | |
| VITAMIN A | INACTIVE INGREDIENT | 81G40H8B0T | 3 | |
| VITAMIN D | INACTIVE INGREDIENT | 9VU1KI44GP | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59051-9067 | 59051-9067-7, 59051-9067-5 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PANCRELIPASE LIPASE | 8MYC33932O | ACTIB |
| PANCRELIPASE AMYLASE | YOJ58O116E | ACTIB |
| PANCRELIPASE PROTEASE | 3560D81V50 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET / ORAL | 2 mg | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | OINTMENT / TOPICAL | NA | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.64 mg | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, CHEWABLE / ORAL | 0.1 mg | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SOLUTION / ORAL | 1.05 mg/1ml | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SYSTEM / TOPICAL | 0.1 mg | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | FILM, SOLUBLE / BUCCAL | 0.07 mg | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, FILM COATED / ORAL | 246 mg | ||
| ALPHA-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | CAPSULE / ORAL | 16 mg |
Adverse event summaries are temporarily unavailable. Other product information remains available.